ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals Inc (TARS)

46.93
0.37
(0.79%)
At close: January 16 4:00PM
46.92
-0.01
( -0.02% )
After Hours: 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
46.92
Bid
46.38
Ask
48.00
Volume
429,605
45.6125 Day's Range 47.25
20.0818 52 Week Range 57.14
Market Cap
Previous Close
46.56
Open
46.50
Last Trade Time
16:08:30
Financial Volume
$ 19,958,291
VWAP
46.4573
Average Volume (3m)
771,857
Shares Outstanding
38,226,929
Dividend Yield
-
PE Ratio
-13.07
Earnings Per Share (EPS)
-3.55
Revenue
17.45M
Net Profit
-135.89M

About Tarsus Pharmaceuticals Inc

Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex ... Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Dover, Delaware, USA
Founded
-
Tarsus Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TARS. The last closing price for Tarsus Pharmaceuticals was $46.56. Over the last year, Tarsus Pharmaceuticals shares have traded in a share price range of $ 20.0818 to $ 57.14.

Tarsus Pharmaceuticals currently has 38,226,929 shares outstanding. The market capitalization of Tarsus Pharmaceuticals is $1.78 billion. Tarsus Pharmaceuticals has a price to earnings ratio (PE ratio) of -13.07.

TARS Latest News

Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY® and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care

Advancing TP-04 (lotilaner ophthalmic gel) for the potential treatment of Ocular Rosacea, another large, underserved eye disease with no FDA-approved therapy; Initiation of Phase 2 study planned...

Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements

Generated $48.1 million in XDEMVY® net product sales driven by more than 41,400 bottles delivered to patients in the third quarter Strengthened payer coverage highlighted by securing the two...

Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors

Humana CMO brings more than two decades of experience driving innovative, value-based initiatives designed to improve patient outcomes IRVINE, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Tarsus...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-7.13-13.191489361754.0554.3843.61101395547.33989606CS
4-6-11.337868480752.9257.1443.6176279952.53626678CS
127.819.938650306739.1257.1438.47877185748.69339403CS
2618.6465.912305516328.2857.1420.081873783938.39583847CS
5224.79112.01988251222.1357.1420.081871083535.4221977CS
15626.71132.16229589320.2157.1410.800139574927.96806658CS
26028.62156.39344262318.363.6910.800129510428.20465848CS

TARS - Frequently Asked Questions (FAQ)

What is the current Tarsus Pharmaceuticals share price?
The current share price of Tarsus Pharmaceuticals is $ 46.92
How many Tarsus Pharmaceuticals shares are in issue?
Tarsus Pharmaceuticals has 38,226,929 shares in issue
What is the market cap of Tarsus Pharmaceuticals?
The market capitalisation of Tarsus Pharmaceuticals is USD 1.78B
What is the 1 year trading range for Tarsus Pharmaceuticals share price?
Tarsus Pharmaceuticals has traded in the range of $ 20.0818 to $ 57.14 during the past year
What is the PE ratio of Tarsus Pharmaceuticals?
The price to earnings ratio of Tarsus Pharmaceuticals is -13.07
What is the cash to sales ratio of Tarsus Pharmaceuticals?
The cash to sales ratio of Tarsus Pharmaceuticals is 101.8
What is the reporting currency for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Tarsus Pharmaceuticals?
The latest annual turnover of Tarsus Pharmaceuticals is USD 17.45M
What is the latest annual profit for Tarsus Pharmaceuticals?
The latest annual profit of Tarsus Pharmaceuticals is USD -135.89M
What is the registered address of Tarsus Pharmaceuticals?
The registered address for Tarsus Pharmaceuticals is 3500 S DUPONT HWY, DOVER, DELAWARE, 19901
What is the Tarsus Pharmaceuticals website address?
The website address for Tarsus Pharmaceuticals is www.tarsusrx.com
Which industry sector does Tarsus Pharmaceuticals operate in?
Tarsus Pharmaceuticals operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ENVBEnveric Biosciences Inc
$ 0.481
(35.11%)
2.06M
NUKKNukkleus Inc
$ 25.34
(19.90%)
140.92k
UBCPUnited Bancorp Inc
$ 14.02
(10.22%)
375
CRKNCrown Electrokinetics Corporation
$ 0.0856
(7.81%)
577.61k
ISPCiSpecimen Inc
$ 2.91
(6.89%)
85.16k
SKYQSky Quarry Inc
$ 1.26
(-8.70%)
62.08k
RIMEAlgorhythm Holdings Inc
$ 0.0388
(-6.28%)
3.1M
CTCXCarmell Corporation
$ 0.545
(-5.22%)
4.23k
XLOXilio Therapeutics Inc
$ 1.1015
(-5.04%)
895
ORKTOrangeKloud Technology Inc
$ 3.85
(-4.94%)
63.92k
RIMEAlgorhythm Holdings Inc
$ 0.0388
(-6.28%)
3.1M
ENVBEnveric Biosciences Inc
$ 0.481
(35.11%)
2.06M
LBRDKLiberty Broadband Corporation
$ 75.85
(0.01%)
1.78M
NVDANVIDIA Corporation
$ 133.66
(0.05%)
1.51M
CMCSAComcast Corporation
$ 36.31
(0.08%)
1.28M

Your Recent History

Delayed Upgrade Clock